Follow‐Up of 3‐Year Luspatercept Treatment in a Transfused ß‐Thalassemia Patient. Bone Marrow: An Undervalued Iron Store

ABSTRACT Introduction Treatment with luspatercept may improve transfusion requirements in transfusion‐dependent thalassemia (TDT), but the improved erythroid maturation in the bone marrow influences body iron distribution. Case Report We report on sequential organ iron measurements in a TDT patient...

詳細記述

書誌詳細

主要な著者:	Matthias Bleeke, Claudia Niekrens, Soumya Datta, Regine Grosse, Filomena Longo, Isabel Molwitz, Roland Fischer
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2025-12-01
シリーズ:	eJHaem
オンライン･アクセス:	https://doi.org/10.1002/jha2.70193
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!